Fig. 5From: Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in gliomaBiological function and pathway analysis in CGGA dataset. a Gene ontology analysis of the biological processes for risk score. b KEGG analysis of the enriched pathways for risk score. c Correlation between risk signature and CSC-related genes in glioma. d Representative images of IHC staining of CD133 and P4HB in glioma samples from the CGGA cohort. d Quantification of expression levels of CD133 and P4HB in IHC stainingBack to article page